Farsad Eskandary
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Felzartamab in Late Antibody-Mediated Rejection (NCT05021484) | Farsad Eskandary | 2021-10-06 |
Track Farsad Eskandary automatically
Every clearance here is in the API, with alerts when new ones post.